Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Omega Healthcare Investors's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.01.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Omega Healthcare Investorscouldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Omega Healthcare Investors's Cash-to-Debt or its related term are showing as below:
BSP:O2HI34'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.15
Current: 0.01
During the past 13 years, Omega Healthcare Investors's highest Cash to Debt Ratio was 0.15. The lowest was 0.00. And the median was 0.02.
BSP:O2HI34's Cash-to-Debt is ranked worse than 88.16% of 870
companies
in the REITs industry
Industry Median: 0.09
vs BSP:O2HI34: 0.01
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Omega Healthcare Investors Cash-to-Debt Related Terms
Omega Healthcare Investors Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BSP:O2HI34 vs DOC, AHR, CTRE: Cash-to-Debt Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Cash-to-Debt vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors (BSP:O2HI34) has a Cash-to-Debt of 0.01 as of Mar. 2026. This is 50% below median its historical median of 0.02. According to the industry distribution chart, Omega Healthcare Investors ranks #767 out of 870 companies in the REITs industry, placing it in the top 88.2%.
Is Omega Healthcare Investors' Cash-to-Debt too high?
Omega Healthcare Investors' current Cash-to-Debt of 0.01 is 50% below median its 10-year median of 0.02. The REITs industry median Cash-to-Debt is 0.09. Omega Healthcare Investors' value of 0.01 is 88.9% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #767 out of 870 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Cash-to-Debt compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #767 out of 870 companies for Cash-to-Debt. This places Omega Healthcare Investors in the lower half of its industry. The industry median Cash-to-Debt is 0.09. Omega Healthcare Investors' value of 0.01 is 88.9% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 0.09, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a REITs company?
The median Cash-to-Debt among REITs companies is 0.09, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Cash-to-Debt of 0.01 is 88.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the REITs industry, the median Cash-to-Debt is 0.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Cash-to-Debt is 0.01, which is 50% below median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Cash-to-Debt is 0.01, which is 50% below median its 10-year median of 0.02 and 88.9% below the REITs industry median of 0.09. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Cash-to-Debt is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Cash-to-Debt: 0.01 (50% below median its 10-year median of 0.02)
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
Industry Position: 88.9% below the REITs median (#767 of 870)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
